Keywords:
хроническая болезнь почек, гемодиализ, ренокардиальный синдром, кардиоваскулярные осложнения, миокардиальное оглушение, ремоделирование миокарда, эндотелиальная дисфункция.References
1. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International Supplements, 2024, Vol. 14, No. 1, pp. 1–164.
2. 2023 ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension. Journal of Hypertension, 2023, Vol. 41, No. 12, pp. 1874–2071.
3. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal, 2021, Vol. 42, No. 36, pp. 3599–3726.
4. KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 Update. American Journal of Kidney Diseases, 2015, Vol. 66, No. 5, pp. 884–930.
5. Ronco C., Haapio M., House A. A., Anavekar N., Bellomo R. Cardiorenal syndrome. Journal of the American College of Cardiology, 2008, Vol. 52, No. 19, pp. 1527–1539.
6. Ronco C., McCullough P. A., Anker S. D., et al. Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative. European Heart Journal, 2010, Vol. 31, No. 6, pp. 703–711.
7. Zannad F., Rossignol P. Cardiorenal syndrome revisited. Circulation, 2018, Vol. 138, No. 9, pp. 929–944.
8. House A. A., Anand I., Bellomo R., et al. Definition and classification of Cardiometabolic-Renal Syndrome: a consensus statement of the Acute Disease Quality Initiative (ADQI) 24. Critical Care, 2021, Vol. 25, No. 1, p. 343.
9. McIntyre C. W. Recurrent myocardial stunning in hemodialysis patients: new insights into an old problem. Current Opinion in Nephrology and Hypertension, 2010, Vol. 19, No. 6, pp. 523–528.
10. Burton J. O., Jefferies H. J., Selby N. M., McIntyre C. W. Hemodialysis-induced cardiac injury: determinants and biobehavioral correlates. Clinical Journal of the American Society of Nephrology, 2009, Vol. 4, No. 5, pp. 914–920.
11. Breidthardt T., Assomull R. G., Anker S. D., et al. Recurrent endotoxemia and systemic inflammation induced by chronic dialysis: a major contributor to myocardial injury. Nephrology Dialysis Transplantation, 2019, Vol. 34, No. 8, pp. 1410–1418.
12. Assa S., Hummel Y. M., Voors A. A., Kuipers J., Westerhuis R., Franssen C. F. Hemodialysis-induced regional myocardial dysfunction is common and associated with intradialytic hypotension. American Journal of Nephrology, 2018, Vol. 47, No. 5, pp. 320–328.
13. Flythe J. E., Kimmel S. E., Brunelli S. M. Rapid fluid removal during dialysis is associated with cardiovascular mortality. Kidney International, 2011, Vol. 79, No. 2, pp. 250–257.
14. Sarioglu S., Selby N. M., McIntyre C. W. Plasma refilling rate and its mismatch with ultrafiltration as a driver of intradialytic cardiovascular instability. Blood Purification, 2022, Vol. 51, No. 4, pp. 315–324.
15. Chou J. A., Kalantar-Zadeh K. Optimization of ultrafiltration rate in hemodialysis: balancing volume control and organ perfusion. Seminars in Dialysis, 2020, Vol. 33, No. 6, pp. 455–464.
16. Cocharan T., Chang T. I. Pathophysiology and management of intradialytic hypotension: a modern perspective. Clinical Journal of the American Society of Nephrology, 2023, Vol. 18, No. 9, pp. 1221–1233.
17. Niwa T. Uremic toxins and cardiorenal syndrome. Journal of Renal Nutrition, 2012, Vol. 22, No. 1, pp. 104–108.
18. Lekawanvijit S., Adhisivam B., Wang B. H., et al. Indoxyl sulfate induces intestinal barrier injury, systemic inflammation, and myocardial fibrosis in experimental uremia. American Journal of Physiology-Heart and Circulatory Physiology, 2016, Vol. 311, No. 3, pp. H745–H753.
19. Sun C. Y., Chang S. C., Wu M. S. Uremic toxin indoxyl sulfate induces myocardial fibrosis through the transcription factor NF-kB and TGF-beta1 pathways. Toxicology Letters, 2014, Vol. 224, No. 2, pp. 211–217.
20. Vanholder R., Pletinck A., Schepers E., et al. Protein-bound uremic toxins: new insights into their pathophysiological role in uremic cardiomyopathy. Toxins, 2020, Vol. 12, No. 3, p. 184.
21. Shanahan C. M., Crouthamel M. H., Kapustin A., Giachelli C. M. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate in vascular transdifferentiation. Circulation Research, 2011, Vol. 109, No. 6, pp. 697–711.
22. Mizobuchi M., Towler D., Slatopolsky E. Vascular calcification: the killer of patients with chronic kidney disease. Journal of the American Society of Nephrology, 2009, Vol. 20, No. 7, pp. 1453–1464.
23. Vervloet M., Cozzolino M. Vascular calcification in chronic kidney disease: mechanisms and clinical implications. Nephrology Dialysis Transplantation, 2017, Vol. 32, No. 5, pp. 766–773.
24. Kuro-o M. Klotho and beta-Klotho: emerging mediators in cardiorenal metabolic health. Nature Reviews Nephrology, 2019, Vol. 15, No. 7, pp. 411–425.
25. Pun P. H. Mechanisms and predictors of sudden cardiac death in advanced chronic kidney disease. Nature Reviews Nephrology, 2014, Vol. 10, No. 4, pp. 224–231.
26. Hougen G., Corson M. A., Shafi T. Electrolyte shifts during hemodialysis and their arrhythmogenic potential. Kidney360, 2021, Vol. 2, No. 8, pp. 1354–1365.
27. Genovesi S., Borghi C., Cosamassima B., et al. Dialysate potassium, serum potassium shifts, and prolonged QTc interval in hemodialysis patients. Nephrology Dialysis Transplantation, 2014, Vol. 29, No. 6, pp. 1224–1231.
28. Смирнов А. В., Добронравов В. А., Каюков И. Г. Кардиоренальный континуум: патогенетические основы превентивной нефрологии. Нефрология, 2011, Т. 15, № 2, с. 10–21.
29. Мухин Н. А., Моисеев В. С. Кардиоренальные взаимодействия: клиническое значение и патогенетические взаимосвязи. Терапевтический архив, 2010, № 6, с. 5–11.
30. Милованов Ю. С., Козловская Л. В., Милованова С. Ю. Хроническая сердечная недостаточность у больных с терминальной стадией хронической болезни почек на программном гемодиализе: особенности патогенеза и терапии. Клиническая нефрология, 2016, № 3, с. 42–49.
31. Томилина Н. А., Волгина Г. В., Бикбов Б. Т. Проблема сердечно-сосудистых заболеваний при хронической почечной недостаточности. Нефрология и диализ, 2003, Т. 5, № 1, с. 15–24.
